South Plainfield, NJ, and Tokyo, JAPAN -- April 14, 2015 -- Leading global genomics service provider, GENEWIZ, announced expansion of its Japanese operations with the appointment of Noboru Kagimoto as Japan Country Manager. GENEWIZ established Japan operations in 2013, and Noboru brings over twenty years of experience in sales and business development to the company.
"We are pleased to welcome Noboru to the GENEWIZ team, and to integrate his expertise in new market development and sales force management as we continue to expand our Japanese operations," stated Steve Manobianco, Vice President, Global Sales & Business Development. "Noboru’s experience in the medical and healthcare markets will bring enhanced insights to accelerate the delivery of streamlined genomics solutions to Japanese researchers."
Manobianco asserted, "the expansion of GENEWIZ Japan is a direct result of the growing needs of the global scientific community. We remain committed to delivering genomics services and solutions that increase researchers’ efficiencies and capabilities, thus enabling advancement of life science research and discoveries."
GENEWIZ is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; Langen, Germany; and Tokyo, Japan.